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OBJECTIVES The purpose of this study was to evaluate the reliability of the pressure half-time (PHT)
method for estimating mitral valve areas (MVAs) by velocity-encoded cardiovascular
magnetic resonance (VE-CMR) and to compare the method with paired Doppler ultrasound.
BACKGROUND The pressure half-time Doppler echocardiography method is a practical technique for clinical
evaluation of mitral stenosis. As CMR continues evolving as a routine clinical tool, its use for
estimating MVA requires thorough evaluation.
METHODS Seventeen patients with mitral stenosis underwent echocardiography and CMR. Using
VE-CMR, MVA was estimated by PHT method. Additionally, peak E and peak A velocities
were defined. Interobserver repeatability of VE-CMR was evaluated.
RESULTS By Doppler, MVAs ranged from 0.87 to 4.49 cm2; by CMR, 0.91 to 2.70 cm2, correlating
well between modalities (r  0.86). The correlation coefficient for peak E and peak A
between modalities was 0.81 and 0.89, respectively. Velocity-encoded CMR data analysis
provided robust, repeatable estimates of peak E, peak A, and MVA (r 0.99, 0.99, and 0.96,
respectively).
CONCLUSIONS Velocity-encoded cardiovascular magnetic resonance can be used routinely as a robust tool to
quantify MVA via mitral flow velocity analysis with PHT method. (J Am Coll Cardiol
2004;44:133–7) © 2004 by the American College of Cardiology FoundationM
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alinical assessment of the severity of mitral stenosis (MS)
epends on both the presence of symptoms and mitral valve
rifice area (1). Evaluation of mitral valve area (MVA) with
oppler echocardiography provides rapid, accurate analysis
f valve disease and serves as a practical gold standard for
linical evaluation. For MVA analysis, the Doppler pressure
alf-time (PHT) method has advantages over the alterna-
ive techniques of Doppler continuity equation method,
wo-dimensional planimetry, and the invasive Gorlin
ethod because of its simplicity and robustness (2).
Velocity-encoded cardiovascular magnetic resonance
CMR) is an established method for quantifying flow
hrough cardiac valves (3–6). It can accurately characterize
alvular regurgitation (7–9), pressure gradients, and stenotic
ortic valves (10,11). However, the reliability of CMR for
uantifying MS has not been defined, particularly in con-
unction with PHT methods. Accordingly, we implemented
velocity-encoded CMR version of the PHT method to
stimate the orifice area of stenotic mitral valves for com-
arison with paired Doppler ultrasound data.
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atients. Seventeen patients (13 women age 45 to 85 years,
ean 64 years) with documented MS undergoing clinically
ndicated echocardiographic exams were recruited. Two
xhibited pure MS; 15 had mixed mitral/other valve disease
predominantly mitral regurgitation, 73%). Patients with
eneral contraindications to CMR were excluded (12). The
tudy protocol received local institutional review board
pproval. Each patient was imaged with CMR and echo-
ardiography successively, but in random order. An experi-
nced CMR technologist and ultrasonographer acquired
mages independently, blind to results of the other, without
hysician supervision to mimic working clinical laboratory
onditions.
ransthoracic echocardiography. Cardiac Doppler stud-
es were obtained using 128-element phased-array imaging
ystems with a 3.5-MHz 128-element phased-array imag-
ng transducer (Acuson Sequoia, Mountainview, California)
nd Doppler at 2.0 MHz. Conventional clinical procedures
or echocardiography were employed with analysis per-
ormed immediately after data recording.
Mitral valve area was determined from continuous-wave
oppler spectra of transmitral flow obtained from the apical
HT four-chamber view by fitting velocity points over the
ange of early diastole with software resident on the imager,
n accordance with standard laboratory practices that use the
inear segments of the data (13). The mitral valve area was
stimated as MVA  220/PHT. Measurements of PHT
nd MVA were based on a representative heartbeat selected
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Quantification of MV Area With MRI and Echocardiography July 7, 2004:133–7y the experienced sonographer in blind fashion indepen-
ent of physician review or concurrence. The E- and
-wave velocities also were measured with the software
ursor tool at the bedside.
MR velocity encoding imaging. Each patient was im-
ged with a 1.5-T MRI (Intera CV, Philips Medical
ystems, Best, the Netherlands) using a five-element
hased-array receive coil. A breathhold, steady-state gradi-
nt echo cine sequence (balanced-fast field echo or
alanced-turbo field echo) was performed first in multiple
iews (e.g., four-chamber, vertical long-axis) to provide the
ualitative functional exam of the mitral valve. With the use
f the free-breathing, retrospectively gated velocity-
ncoding CMR technique, quantitative flow images were
cquired (slice thickness 8 mm, echo time 3.0 ms, repetition
ime 6.0 ms, flip angle 30°, 2 averages, field of view 350 mm,
atrix 128  256, 30 phases per RR interval). The
elocity-encoded CMR series were performed in the left
entricular short-axis plane oriented parallel to the mitral
alve plane, positioned 1.5 cm from the valve plane toward
he apex (Fig. 1a). Typically, each scan required about 3.5
in, depending on heart rate. The maximum encoding
elocity limit (VENC) was set to 1.5 m/s (“through plane”).
f velocity aliasing occurred, the images were reacquired
ith a higher VENC.
Images were transferred to a workstation (EasyVision
5.1, Philips Medical Systems) for quantitative flow anal-
sis. A region of interest (ROI) was drawn on each of the 30
Abbreviations and Acronyms
AF  atrial fibrillation
CMR  cardiovascular magnetic resonance
MS  mitral stenosis
MVA  mitral valve area
PHT  pressure half-time
ROI  region of interest
VENC  velocity encoding (maximum) value
igure 1. (a) The velocity-encoded cardiovascular magnetic resonance (CM
pex. (b) A region of interest (ROI) in the velocity image includes the mitra
ersus time over the cardiac cycle measured by velocity-encoded CMR: note abhases of the cine, including the mitral flow jet to identify
eak velocity (Fig. 1b). The peak flow velocity values within
ach ROI at each phase were exported to a spreadsheet and
plot of peak velocity versus time was constructed over the
ardiac cycle (Fig. 1c). The peak E-wave and peak A-wave
elocities during diastole were defined from the flow velocity
urve. To quantify the PHT objectively, a least-squares
tting technique was used. For fitting a simple linear
quation, all the data points from the peak early filling
elocity during diastole (i.e., peak E) to the linear portion of
he flow velocity curve were included, following the ap-
roach used by the sonographer (Fig. 2). For patients in
trial fibrillation (AF), all the data points during diastole
ere included to measure the PHT. As with ultrasound,
VA was estimated as 220/PHT. All CMR values were
ompared double-blind with Doppler ultrasound measure-
ents.
eproducibility. Interobserver reproducibility for CMR
easurements was also evaluated in ten randomly-selected
atients. Two observers independently defined ROIs, mea-
ured peak E and A, estimated PHT, and calculated MVA.
epeated measurements were compared.
tatistical analysis. To determine the relationship between
MR and echocardiography, a Pearson coefficient of cor-
elation was tested with linear regression analysis. A two-
ailed p value of 0.05 was considered significant. Bland-
ltman analysis (14) was performed to compare the
greement of Doppler and CMR measurements. To evalu-
te interobserver reproducibility for CMR measurements,
earson coefficients of correlation and concordance correla-
ion coefficients (15) were calculated.
ESULTS
n the 17 patients with MS, echocardiographic assessment
f stenosis ranged from trace to severe. Associated signs of
S, such as mitral valve leaflet thickening, mitral regurgi-
ation, and enlarged left atrium, were readily observed on
mage plane was positioned 1.5 cm from the mitral valve plane toward the
jet allowing identification of the peak velocity. (c) Plot of the peak velocityR) i
l flowsence of the peak A-wave (Afib). LA  left atrium; LV  left ventricle.
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ith severe MS were in chronic AF, and two patients
xhibited severe aortic valve insufficiency.
igure 3. Comparison of cardiovascular magnetic resonance (CMR) results
eak A is the maximum velocity at A-wave (c and d). (a) Scatter-plot of t
f the mean results of both methods related to the mean difference. (c)
land-Altman plot of the mean results of both methods related to the m
igure 2. (a) Doppler estimation of the pressure half-time (PHT). (b) All
he linear portion of the flow velocity curve were included to determine thFigure 1a shows a long-axis image with the intersecting
lane selected for velocity-encoded imaging, and Figure 1b
hows the phase image of that selected short-axis plane with
hocardiography: peak E is the maximum velocity at E-wave (a and b), and
ak E obtained by CMR versus echocardiography. (b) Bland-Altman plot
ter-plot of the peak A obtained by CMR versus echocardiography. (d)
ifference. SD  standard deviation.
ty-encoded cardiovascular magnetic resonance data points from peak E to
T by simple linear regression.to ec
he pe
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Quantification of MV Area With MRI and Echocardiography July 7, 2004:133–7he ROI circumscribing the mitral flow jet. The peak
elocity values within each sequential ROI comprised the
itral flow profile. Figure 1c shows CMR recordings of
eak velocity versus time curve for a patient with severe MS
nd AF.
eak E velocity and peak A velocity. The peak E velocity
n 17 patients ranged from 0.44 to 2.26 m/s for echocardi-
graphy and 0.67 to 1.59 m/s for velocity-encoded CMR.
he peak A velocity (15 patients) ranged from 0.57 to 1.95
/s measured by echocardiography and 0.36 to 1.74 m/s by
MR. Figures 3a and 3c show the correlation of peak E
elocity measured from CMR and Doppler (r  0.81, p 
.0001) and the strong correlation of peak A velocity
efined from CMR and echocardiography (r  0.89, p 
.0001). The mean difference of peak E between modalities
as 0.22 m/s (SD  0.26 m/s), and limits of agreement
ere (0.73, 0.29) m/s (Fig. 3b). The mean difference of
eak A was 0.10 m/s (SD  0.20 m/s), and limits of
greement were (0.51 to 0.31) m/s (Fig. 3d).
ressure half-time and mitral valve area. The PHT
alculated from echo Doppler measurements ranged from
9.0 to 252.0 ms; MVA ranged from 0.87 to 4.49 cm2. The
HT obtained by velocity-encoded CMR ranged from 81.5
o 242.6 ms and MVA from 0.91 to 2.70 cm2. The
orrelation between the PHT determined by the two
odalities was significant (r  0.86, p  0.0001). Further-
ore, the intermodality correlation of the MVA calculated
sing PHT correlated well (r  0.80, p  0.0001). The
ean difference of MVA between the two modalities was
.50 cm2 (SD  0.59 cm2) and limits of agreement were
1.68 to 0.68) cm2. If data from the two patients with
evere aortic regurgitation were excluded, the relationship
orrelated even more strongly (r  0.92, p  0.0001) (Fig.
a), with the mean difference of MVA between modalities
eing 0.32 cm2 (SD  0.30 cm2) with limits of agreement
0.91 to 0.28) cm2 (Fig. 4b).
eproducibility. Figure 5 illustrates excellent concordance
igure 4. The mitral valve area (MVA) estimated using pressure half-tim
CMR) results to echocardiography. (a) MVAs obtained by CMR correlat
nd 2 standard deviation (SD) limits of MVA estimated by both methodetween MVA analyses by two independent observers (r  a.96, p  0.0001) for ten patients with MS. The CMR
alve size estimates by each observer also correlated well
ith Doppler (r  0.94 and 0.89; p  0.001). The
omponent measurements of peak E, peak A, and PHT also
orrelate well between observers (r  0.99, 0.99, and 0.83,
espectively; p 0.01). Table 1 summarizes the comparison
f all the interobserver measures with both the Pearson
orrelation coefficient (r), and the reproducibility index,
oncordance correlation coefficient.
ISCUSSION
his study demonstrates the ability of velocity-encoded CMR
o quantify MVA in patients with MS using the PHT method
n a manner directly analogous to that employed in echocar-
iographic laboratories with Doppler echocardiography. For
valuation of MS, important strengths of CMR are that
isualization of the spatial configuration of the mitral valve is
xcellent and quantification of trans-valvular flow jets is unre-
roach: comparison of velocity-encoded cardiovascular magnetic resonance
ll with those by ultrasound. (b) Bland-Altman plot of the mean difference
angles  patients with AI; other abbreviations as in Figure 3.
igure 5. Interobserver reproducibility of mitral valve area using velocity-
ncoded cardiovascular magnetic resonance. The mitral valve area for ten
atients analyzed by first (white bars) and second (black bars) observer is
hown. Overall correlation between observers was r  0.96 (p  0.0001),e app
ed we
s. Tris detailed in Table 1. Abbreviations as in Figure 3.
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July 7, 2004:133–7 Quantification of MV Area With MRI and Echocardiographytricted by echo windows. Although velocity-encoded CMR
as been used clinically for some time (16–19), few studies
ave dealt with methods for quantification of valve disease other
han regurgitation. The results of this study confirmed the
ndings of other studies regarding valve flow velocities and
ressure gradients, but importantly extend the methodology to
irect calculation with CMR of valve areas, which is critical for
atient management.
Although echocardiographic implementation of the PHT
ethod serves as a simple and practical gold standard for
linical evaluation of MS in routine patient care situations,
ome limitations exist (20). For example, in cases of aortic
nsufficiency, ventricular diastolic filling retrograde from the
orta might cause the mitral gradient to decline prema-
urely, decrease PHTs artificially, and cause an overestima-
ion of MVA. Indeed, most studies have reported that PHT
verestimates MVA in the setting of coexisting moderate to
evere aortic insufficiency (21,22). We observed that CMR
ended to mildly underestimate peak velocities as compared
ith echocardiography. Insufficient temporal resolution
ight distort the flow velocity as a function of the phase of
he cardiac cycle, particularly with respect to the greater
emporal sampling frequency of echo Doppler data. Fortu-
ately, recent reports indicate that CMR temporal resolu-
ion may be substantially increased without loss the accuracy
n complex flow patterns (23).
In conclusion, these data indicate that MVA can be quan-
ified with the PHT method robustly and routinely with a
ingle velocity-encoded CMR acquisition. Furthermore, these
ethods, which can be substantially automated to provide
epeatable and objective assessments, are easily adaptable to any
R scanner. Together with recent demonstrations of the
obustness of related MR methods for computation of aortic
alve areas (11), we propose that the clinical utility of CMR for
outine assessment of valvular disease might be viewed as
quivalent to that of echocardiography.
eprint requests and correspondence: Dr. Shelton D. Caruth-
rs, Cardiovascular Division, Washington University School of
edicine, Campus Box 8086, 660 South Euclid Avenue, St.
ouis, Missouri 63110. E-mail: scaruthers@cmrl.wustl.edu.
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